Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an update.
Teigland Eiendom AS, a company closely linked to Lifecare ASA board member and primary insider Trine Teigland, has exercised 4,787,552 Series 1 warrants to subscribe for an equal number of new Lifecare shares at NOK 0.3342 per share. After this transaction, Teigland Eiendom holds 12,682,136 shares plus remaining warrants in both Series 1 and Series 2, increasing its stake and reinforcing insider support for the company.
The exercise occurs during the limited Series 1 warrant exercise window, after which unexercised warrants will lapse and could dilute non-participating holders. Lifecare expects the resulting share capital increase to be registered in late March 2026, with new shares delivered shortly thereafter, modestly strengthening the company’s capital base ahead of its continued development of glucose monitoring technology.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a primary emphasis on next-generation continuous glucose monitoring systems. The company’s osmotic pressure-based sensor platform is designed to detect and track a broad range of molecules in humans and pets, positioning it within the advanced medical diagnostics and digital health market.
Average Trading Volume: 2,931,799
Current Market Cap: NOK69.55M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.